1. Compressive stress-mediated p38 activation required for ERα + phenotype in breast cancer
   Pauliina M. Munne et al, 2021, Nature Communications CrossRef
2. Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers
   Dena A. J. Ahmad et al, 2016, Breast Cancer Research and Treatment CrossRef
3. Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
   Simon J. Johnston et al, 2018, BMC Cancer CrossRef
4. Synthesis and molecular docking study of new benzofuran and furo[3,2- g ]chromone-based cytotoxic agents against breast cancer and p38α MAP kinase inhibitors
   Kamelia M. Amin et al, 2018, Bioorganic Chemistry CrossRef
5. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds
   Omaima M. Abdelhafez et al, 2019, Bioorganic & Medicinal Chemistry CrossRef
6. Beneficial effects of estrogens in obstructive sleep apnea hypopnea syndrome
   Lixiu Zhang et al, 2020, Sleep and Breathing CrossRef
7. Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
   Junnan Xu et al, 2017, Oncology Letters CrossRef
8. Phosphorylation of cell cycle and apoptosis regulatory protein-1 by stress activated protein kinase P38γ is a novel mechanism of apoptosis signaling by genotoxic chemotherapy
   Jaganathan Venkatesh et al, 2024, Frontiers in Oncology CrossRef
9. Continuous Exposure of Breast Cancer Cells to Tamoxifen Upregulates GPER-1 and Increases Cell Proliferation
   Luis Molina et al, 2020, Frontiers in Endocrinology CrossRef
10. Low serum gastrin associated with ER+ breast cancer development via inactivation of CCKBR/ERK/P65 signaling
    Li-Li Meng et al, 2018, BMC Cancer CrossRef
11. GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer
    Luis Molina et al, 2017, Expert Opinion on Therapeutic Targets CrossRef
12. C5aR deficiency attenuates the breast cancer development via the p38/p21 axis
    Jian Chen et al, 2020, Aging CrossRef
13. Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
    Reyhaneh Farghadani et al, 2021, Cancers CrossRef
14. Molecularly targeted therapies for p53-mutant cancers
    Dekuang Zhao et al, 2017, Cellular and Molecular Life Sciences CrossRef
15. Possible role of phytoestrogens in breast cancer via GPER-1/GPR30 signaling
    Luis Molina et al, 2018, Clinical Science CrossRef
16. Star-related lipid transfer protein 10 (STARD10): a novel key player in alcohol-induced breast cancer progression
    Andrea Floris et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef